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Abstract
Background: In children and adolescents, the prevalence rate of migraine with aura is 1.6%. Few studies concerning
migraine with aura features in paediatric population have been reported.
Aim: The aim of our study was to investigate clinical features of aura in a retrospective cohort of children with migraine
with aura. Furthermore, we studied whether the International Classification of Headache Disorder (ICHD) 3 beta
version criteria could efficiently detect migraine with aura in a paediatric population.
Results:We included 164 patients who experienced aura associated with headache (mean age 9.92 2.64 years). When
the ICHD-II criteria were used, a final diagnosis of migraine with typical aura was obtained in 15.3% of patients, probable
migraine with typical aura in 13.4%, and typical aura with headache in 61.8%, while in in 9.5% of patients the diagnosis was
undetermined. According to ICHD-3 beta, we diagnosed migraine with typical aura in 77.7% of patients, probable
migraine with typical aura in 13.4%, and an undetermined diagnosis in 9.5% (less than two attacks).
Conclusion: Aura features did not depend on age and were similar to those of adults. However, the headache could be
difficult to classify if headache duration was considered. In this view, the ICHD-3 beta offers the advantage of not
considering headache features, including pain duration, for the diagnosis of migraine with typical aura, thus making this
diagnosis easier in children and adolescents.
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Introduction
Migraine with aura (MWA) is described in the
International Classification of Headache Disorders
(ICHD) 3 edition (beta version) as ‘‘recurrent attacks,
lasting minutes, of unilateral fully reversible visual, sen-
sory or other central nervous system symptoms that
usually develop gradually and are usually followed by
headache and associated with migraine symptoms.
Aura symptoms spreads gradually over 5 to 60 min-
utes. . . and are accompanied, or followed within
60 minutes, by headache’’ (1). Though less commonly,
headache may be completely absent.
The prevalence of migraine in children and adoles-
cents has been reported to be between 3 and 23% (2–6).
MWA prevalence is substantially lower, with an aver-
age rate of 1.6% (7). Patients with migraine attacks
with aura could also have attacks without aura (1).
Few studies concerning MWA features in a paediatric
population are reported (8,9).
Compared to the ICHD-I classification, the
ICHD-II criteria have increased the sensitivity of
the diagnosis of migraine without aura (MOA) in
children from 21% to 53% (10,11). However, these
criteria still failed to detect about half of paediatric
migraine, particularly due to the difficulty in distin-
guishing tension-type headache from migraine in
young children (7). In the third edition of the
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ICHD criteria, the duration of the migraine attack in
children and adolescent was shifted from 1–72 hours
to 2–72 hours (1), being inadequate especially for
young children (12).
The latest version of the ICHD criteria proposes a
major novelty for the diagnosis of MWA. While the
ICHD-II distinguished MTA (migraine with typical
aura) from typical aura with headache (THA) depend-
ing on pain features (migrainous or not), in the ICHD-3
beta the headache features are not considered for the
diagnosis of MTA. In particular, in the section concern-
ing MTA (1), the ICHD-3 beta recognises two entities:
Typical aura with headache and typical aura without
headache (1). So, when the aura criteria are met, MTA
can be diagnosed independently of whether the pain
meets the criteria of migraine. This could be of great
benefit for the diagnosis of MWA in paediatric
patients, as it allows us to overtake the limitations
of the previous criteria concerning the duration of
pain (12).
The aims of our study were: a) To investigate the
clinical characteristics of aura in a retrospective
cohort of migraine children experiencing aura symp-
toms, and b) to compare ICHD-II and the ICHD-3
beta criteria for the diagnosis of MWA in a paediatric
population.
Materials and methods
Selection and classification of the patients
We retrospectively reviewed the charts of patients
attending the Headache Centre of Bambino Gesu`
Pediatric Hospital in a period from January 2002 to
December 2011.
Patients who presented with neurological symptoms
suggesting aura were selected, and those in whom a
primary headache was diagnosed were included. In
particular, the diagnosis of primary headache was
based on the following main elements: a) all selected
children were followed for at least 1 year and no dif-
ferent headache aetiology could be identified in this
period, b) all children had a normal neurological
examination, including fundus oculi examination,
through the entire period considered, c) all children
younger than 5 years had a neuroradiological examin-
ation (brain MRI or CT scan), which had to be
normal. Other elements for the diagnosis of primary
headache were: a) at least one relative with primary
headache (first-degree relatives), and b) the coexistence
or not of the so-called childhood periodic syndromes
and related symptoms (cyclical vomiting syndrome,
abdominal migraine, benign paroxysmal vertigo,
benign paroxysmal torticollis, limb pain and motion
sickness) (13,14). None of the included children
suffered from diseases potentially associated with sec-
ondary headache.
We considered pain localisation (orbital, frontal,
temporal, vertex, parietal, occipital or diffuse), quality
of pain (throbbing, constrictive, trafictive or dull),
seven classes of duration of pain (<5 minute; 5–30 min-
utes; 30 minutes to 1 hour; 1–2 hours; 2–4 hours; 4–24
hours and >24 hours), intensity (from 1 to 3), fre-
quency of attacks (sporadic, multi-monthly, monthly,
multi-weekly and weekly), and vegetative symptoms
associated such as nausea, vomiting, photo and phono-
phobia (none of these, only 1, 2, 3 or 4). Aura charac-
teristics included: Type (visual, sensitivity, motor or
aphasia), duration (less than 5 minutes, between 5
and 10 minutes, between 10 and 30 minutes, between
30 minutes and 1 hour and more than 2 hours) and
timing of aura manifestations with respect to headache
(pre-ictal: 5–60 minutes before headache, ictal: Less
than 5 minutes before headache; or post-ictal: Within
60 minutes after headache).
The final diagnosis of headache was made according
to either the ICHD-II or ICHD-3 beta criteria and the
results were compared. Diagnosis of migraine with typ-
ical aura (MTA) was made when the ICHD criteria
were fully satisfied, while probable migraine with
typical aura (pMTA) was diagnosed when the ICHD
criteria were partially satisfied. When we used the
ICHD-II criteria, typical aura with headache (TAH)
was diagnosed when aura criteria were met, but head-
ache pain did not fulfil the criteria for migraine. The
patients in which neither the criteria for aura nor
those for migraine were satisfied were classified as
undetermined.
Statistical analysis
Statistical analysis was conducted by using the dedi-
cated software MYSTAT 12 (v.12.02.). We used a 2
test for the correlation analysis and a logistic regression
for the regression analysis. Values of p< 0.05 were con-
sidered significant.
Characteristics of aura (type, duration, and timing
of onset with respect to headache) were compared
among different groups of ages (less than 6 years,
between 7–10 years, between 11 and 14 years, more
than 15 years) using the 2 test.
Regression analysis was used to verify significant
correlation between diagnoses (MTA, pMTA, THA,
undetermined) and headache features (duration of
headache, pain localisation, quality of pain, intensity
and vegetative accompanying symptoms); between
diagnosis and aura features (type, timing, and dur-
ation of aura); between aura characteristics and head-
ache features, and between age/gender and aura
features.
2 Cephalalgia 0(0)
Results
We included 164 patients who experienced aura asso-
ciated to headache (37.8 % males and 62.2% females).
The mean age of headache onset was 9.92 2.64 years
(range: 5–17 years).
Pain localisation was frontal (43.7%), temporal
(35.3%), orbital (10%), diffuse (3.3%), parietal
(2.5%), referred to vertex (4.2%) and occipital
(0.8%). Headache quality was reported as: Throbbing
in 52.6%, constrictive in 37.8%, trafictive in 6.4% and
dull in 3.2% of cases. Attack duration was between
1 and 2 hours in 34.1% of the patients, between
5 and 30 minutes in 20.1%, less than 5 minutes in
12.8%, between 2 and 4 hours in 14.6%, between
30 minutes and 1hour in 12.8%, more than 24 hours
in 4.3% and between 4 and 24 hours in 1.2%. Despite
the main duration of headache being between 1 and
2 hours both in males and in females, pain duration
was shorter than 1 hour in 55.4% of males and
36.1% of females (p< 0.005), while it was longer than
2 hours in only 14.9% of males and 25.8% of females
(p> 0.005). Intensity of pain was in a range between a
minimum of 1 and a maximum of 3; the mean value was
2.66 0.572. Attack frequencies were grouped in five
categories: Sporadic (44.5%), monthly (28%), multi-
weekly (13.4%), weekly (9.8%) and multi-monthly
(4.3%). We also considered the associated vegetative
symptoms that may accompany headache (nausea,
vomiting, photophobia and phonophobia). Two symp-
toms were reported by 30.7% of patients, three symp-
toms in 23.5%, one symptom in 15% and all of them in
11.8%. None of these conditions were referred to by
18.9% of patients. Photophobia was the most prevalent
associated symptom (64.6%), followed by phonopho-
bia (55.5%), nausea (36%) and vomiting (30.5%).
Headache features are summarised in Figure 1.
Visual symptoms were reported in most attacks with
aura (93.2%) and included positive (bright spots,
flashes of light or scintillating scotoma) and negative
(loss of vision) phenomena. Somatosensory (5.5%),
motor (0.6%), and aphasic (0.6%) auras were less rep-
resented in our patients. Forty-two patients (25.1%)
experienced a second type of aura with somatosensory
(64.3%), speech (23.8%: 14.3% dysarthria and 9.5%
aphasia), and motor (11.9%) disturbances. Aura dur-
ation was less than 5 minutes in 18.8% of patients,
between 5 and 10 minutes in 41.3%, between 10 and
30 minutes in 28.3%, between 30 minutes and 60 min-
utes in 10.1%, and more than 120 minutes in 1.4%.
Pre-ictal aura was present in 69.1% of patients, ictal
aura in 21.1% and post-ictal aura in 9.7%.
Characteristics of aura in the different age groups are
reported in Tables 1–3. Features of aura did not show
significant differences when different ages have been
considered (p> 0.05).
When the ICHD-II criteria were used, a final diag-
nosis of MTA was obtained in 15.3% of patients,
pMTA in 13.4%, and TAH in 61.8%, while in in
9.5% of patients the diagnosis was undetermined
(Figure 2). pMTA patients could not be included in
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Figure 1. Headache characteristics (% of patients). Intensity:
1 mild; 2 moderate; 3 severe; vegetative symptoms (nausea,
vomiting, photophobia and phonophobia): 0: None; 1: One
symptom; 2: Two associated symptoms; 3: Three associated
symptoms; 4: Four associated symptoms.
Table 1. Aura types considering group ages (%); p> 0.05.
<6 yrs 7–10 yrs 11–14 yrs >15 yrs
Visual 8.5 43.5 36.2 4.9
Sensitivity 1.2 3.06 1.2 0.0
Motor 0 0 0.6 0.0
Aphasia 0 0.6 0 0.0
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the MTA group, since all of them showed aura lasting
less than 5min and 65% presented pain duration
shorter than 1 h. Among the TAH patients, 94.3%
showed a too-short (5–60min) pain duration.
When the ICHD-3 beta criteria were applied, MTA
was diagnosed in 77.7% of patients and pMTA in
13.4%, with a positive predictive value (PPV) of 85%,
while the diagnosis was undetermined in 9.5% of
patients. The pMTA patients did not fulfil the criteria
for MTA diagnosis, since all of them (100%) presented
aura duration shorter than 5 minutes.
The patients with undetermined diagnosis were the
same independently of the use of either ICHD-II or
ICHD-3 beta criteria. They had had less than two head-
ache attacks with aura. We found no patients with aura
without headache (Figure 2).
For the regression analysis, we considered the diag-
noses obtained using the ICHD-3 beta criteria. We
found that phonophobia and photophobia were asso-
ciated with MTA and pMTA (p< 0.001). Aura charac-
teristics did not correlate to pain characteristics,
gender, or age (p> 0.05).
Discussion
Our study addressed analysis of the clinical character-
istics of migrainous aura in a pediatric population and
tested the diagnostic power of the new ICHD-3 beta
criteria for the diagnosis of MWA.
As for the analysis of the aura features, we found
that the visual symptoms are more frequent (93%) than
somatosensory, motor, and speech disturbances. As in
adults (15), aura anticipates headache onset in most
cases (69.1%) and its duration ranges from 5 to
60min. When we divided our patients into four differ-
ent age groups (<6 years, 7–10 years, 11–14 years, >15
years), no difference in the aura characteristics were
found between these groups.
Lanzi et al. reported a group of 47 young migraines
with aura patients. Visual and sensory disturbances
were the most commonly described symptoms; a
motor deficit was present in 10 out of their 47 cases.
Other disturbances such as vertigo attacks, aphasia,
spatial disorientation, loss of consciousness or a
decreased level of consciousness with the appearance
of automatic movements, were much rarer (16).
Balottin et al. conducted a prospective study in 45
patients affected by migraine with aura, evaluating clin-
ical characteristics and aura evolution during attack.
The aura propagated slowly, with a pattern corres-
ponding to a cortical pathway in the postero-anterior
direction in 71% of their patients, while it was only
visual in 40%. Headache had a better prognosis in
terms of frequency of the attacks, when symptoms
9.5%
15.3%
13.4%
9.5%
77.1%
13.4%MTA
(a) (b)
pMTA
TAH
Undetermined61.8%
Figure 2. Comparison between diagnoses made using either the ICHD-II (a) or ICHD-III beta (b) criteria.
Table 2. Aura duration considering groups ages (%). min:
minutes; p> 0.05.
<6 yrs 7–10 yrs 11–14 yrs >15 yrs
<5min 2.1 7.9 8.7 0
5–10min 5.8 15.9 15.9 3.6
10–30min 2.1 15.2 9.4 1.4
30–60min 0 7.2 2.9 0.0
>120min 0 0.7 0.7 0.0
Table 3. Aura timing considering groups ages (%); p> 0.05.
<6 yrs 7–10 yrs 11–14 yrs >15 yrs
Pre-ictal 5.7 32.5 26.8 4.1
Ictal 1.6 11.3 6.5 1.6
Post-ictal 0.0 5.7 4.1 0
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kept being only visual (17). In disagreement with these
results, in a study of 137 patients Termine et al. con-
cluded that patients experiencing only visual aura had a
lower aura remission rate compared with those with
visual, sensory, and aphasic aura symptoms (36.8%
vs. 61.5%). Furthermore, a shorter headache duration
(<12 hours) and the presence of EEG abnormalities at
baseline were significant predictors of aura remission at
follow-up (17).
Taga et al. recently reported 283 instances of MWA
with paediatric onset that were compared with adult
onset. In both groups of patients, visual aura was the
most common type of aura, followed by sensory and
speech disturbances. In the paediatric group, aura with-
out headache was significantly less frequent (1.8 vs.
5.3%); furthermore, headache had migraine character-
istics in a higher proportion of cases (90.1 vs. 82.6%).
A family history of MWA was significantly more fre-
quent among cases with paediatric onset (31.1% vs.
16.9%). Males, but not females with paediatric MWA
more frequently had a comorbid migraine without aura
(27.6 vs. 16.8%). Among cases with paediatric onset,
we did not find any significant differences between
males and females (18).
Genizi et al. reported 262 migrainous children, of
whom 26.2% had MWA. Multiple logistic regression
analysis revealed that older age (p< 0.02), family his-
tory of aura (p< 0.02), and (lack of) TTH (p< 0.01)
were significant predictors of aura, whereas gender
was not significant (p> 0.20). Children who had
migraine with aura were less likely to have mixed head-
aches than children who did not have aura (OR: 0.26,
95 % CI: 0.11–0.63; p< 0.01) (19).
Compared to the previous studies, we investigated
the largest population of migraine children and adoles-
cents experiencing aura. Our results confirm the aura
characteristics described in previous studies and show
that they are not different from those found in adults
(1,15). As for the headache characteristics associated
with aura symptoms, our patients more often experi-
enced a throbbing fronto-temporal pain, lasting less
than 4 hours (94.5%) and usually associated with
photophobia (64.6%) and phonophobia (55%). In
our population, the average frequency of migraine
attacks was quite low (less than four attacks per
month in 76.8% of patients).
As far as the diagnostic criteria are concerned, we
found that the rate of MTA diagnosis is higher with the
new than with the previous ICHD criteria. While the
ICHD-II distinguishes MTA from THA depending on
the pain features, in the ICHD-3 beta the headache
features are not relevant for the diagnosis of MTA.
This novelty provides a significant benefit for the
diagnosis of MWA in paediatric patients, where the
headache attack duration can be shorter than in
adults (12). As consequence of this change, all our
patients classified as TAH according to the ICHD-II
shifted to the MTA group when ICHD-3 beta criteria
were applied.
Compared to the ICHD-II, the third version of the
ICHD criteria did not reduce the number of patients
with a diagnosis of pMTA, since the shortest duration
of aura symptoms was kept at 5 minutes. However, this
excludes more than 10% of patients from the diagnosis
of MTA.
Limitations of the study
Our study shows some limitations that are to be con-
sidered. First, our results are issued from a retrospect-
ive study, thus the new criteria need to be confirmed
and validated in a prospective multicentre trial.
However, it is to be underlined that we had the possi-
bility to describe the largest series of children and ado-
lescents with MWA. Second, we are aware that
determining the duration of the pain attack and/or
aura symptoms in children, especially the younger
ones, may be subject to mistakes. This is because it
can be difficult to understand when the attack and/or
the aura truly end. Furthermore, considering the child’s
behaviour (recommencement of normal activity) can
lead to bias in judging that pain and/or aura symptoms
ended while the child still had mild pain. This possibil-
ity may have artificially shortened both the headache
attack and aura duration in some of our youngest chil-
dren. Third, a further limitation concerns the difficulty
in recognising aura symptoms in very young children
who cannot communicate or describe them. Therefore,
although the diagnostic workup for children suffering
from headache is similar to that used for adults, certain
peculiarities must be considered (e.g. non-verbal
behaviours).
Conclusions
In conclusion, our paediatric population shows aura
features that do not depend on age and are similar to
those of adult patients. However, a final diagnosis of
MTA could be less often reached when using
the ICHD-II criteria, which consider headache dur-
ation. In this view, the ICHD-3 beta criteria offer
the advantage of not considering headache features,
including pain duration, thus increasing the MTA diag-
nosis rate.
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Clinical implications
. The paediatric population shows aura features that do not depend on age and are similar to those of adult
patients.
. Children with migraine showed a shorter duration of attacks than adults.
. ICHD-3 beta criteria offer the advantage of not considering headache features, including pain duration, thus
increasing the MTA diagnosis rate.
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